Company Information

Company BrightGene Pharmaceutical Co., Ltd. 博瑞制药(苏州)有限公司
www.bright-gene.com
Type:
Company
Country:
China
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Privately Held
Global Compact Status:
Active
Participant Since
20 September 2023
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2024